证券之星消息，截至2025年10月14日收盘，稳健医疗(300888)报收于38.73元，上涨0.52%，换手率 0.82%，成交量4.74万手，成交额1.84亿元。 10月14日的资金流向数据方面，主力资金净流入1446.65万元，占总成交额7.86%，游资资金净流入 153.87万元，占总成交额0.84%，散户资金净流出1600.52万元，占总成交额8.69%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-10-14 | 38.73 | 0.52% | 1446.65万 | 7.86% | 153.87万 | 0.84% | -1600.52万 | -8.69% | | 2025-10-13 | 38.53 | -2.31% | -766.54万 | -3.76% | -298.87万 | -1.46% | 1065.42万 | 5.22% | | 2025-10-10 | 3 ...

Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 42.36 yuan, reflecting a 1.17% increase as of August 29, 2025, despite a net outflow of main funds [1][2]. Financial Performance - Steady Medical reported a main revenue of 5.296 billion yuan for the first half of 2025, representing a year-on-year increase of 31.31% [3]. - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year, while the net profit after deducting non-recurring gains and losses was 461 million yuan, increasing by 40.9% [3]. - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% [3]. Market Position - Steady Medical's total market capitalization is 24.667 billion yuan, ranking 4th in the beauty and personal care industry [3]. - The company has a net asset of 12.276 billion yuan, ranking 1st in the industry, and a net profit of 492 million yuan, ranking 3rd [3]. - The company's price-to-earnings ratio (P/E) is 25.07, which is lower than the industry average of 31.93, ranking 3rd [3]. Fund Flow Analysis - On August 29, 2025, the main funds experienced a net outflow of 47.5893 million yuan, accounting for 6.42% of the total transaction amount [1][2]. - Retail investors showed a net inflow of 48.1353 million yuan, representing 6.49% of the total transaction amount on the same day [1][2]. - Over the past five days, the stock has seen fluctuations in fund flows, with varying levels of net inflows and outflows from main and retail investors [2]. Institutional Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4]. - The average target price set by institutions over the past 90 days is 55.82 yuan [4].

Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 41.87 yuan, reflecting a 2.25% increase on August 28, 2025, amidst varying capital flows from different investor groups [1][2]. Financial Performance - For the first half of 2025, Steady Medical reported a main revenue of 5.296 billion yuan, representing a year-on-year increase of 31.31% - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year - The net profit after deducting non-recurring gains and losses was 461 million yuan, marking a 40.9% increase year-on-year - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% year-on-year [3]. Market Position - Steady Medical's total market capitalization stands at 24.382 billion yuan, significantly higher than the industry average of 11.443 billion yuan, ranking 4th in the industry - The company has a net asset value of 12.276 billion yuan, leading the industry with a ranking of 1st - The company's net profit of 492 million yuan ranks 3rd in the industry, while its price-to-earnings ratio (24.78) and price-to-book ratio (2.12) rank 4th and 5th respectively [3]. Investor Sentiment - Over the past 90 days, 19 institutions have rated the stock, with 16 buy ratings and 3 hold ratings - The average target price set by institutions for the stock is 55.82 yuan [4].

Group 1 - The stock of Steady Medical (300888) closed at 41.89 yuan on August 20, 2025, with an increase of 1.48% and a turnover rate of 4.54% [1] - The net inflow of main funds was 14.12 million yuan, accounting for 4.25% of the total transaction amount, while retail investors experienced a net outflow of 6.98 million yuan, representing 2.1% of the total [1][2] - Over the past five days, the stock has seen fluctuations in fund flows, with significant net outflows from retail investors on several days [2] Group 2 - Steady Medical's total market value is 24.39 billion yuan, with a net asset of 12.15 billion yuan, and a net profit of 249 million yuan, ranking 4th, 1st, and 3rd respectively in the beauty and personal care industry [3] - The company's main revenue for Q1 2025 was 2.61 billion yuan, a year-on-year increase of 36.47%, and the net profit attributable to shareholders was 249 million yuan, also up 36.26% year-on-year [3] - The company's gross profit margin stands at 48.46%, which is higher than the industry average of 42.27% [3] Group 3 - In the last 90 days, 15 institutions have rated the stock, with 13 buy ratings and 2 hold ratings, and the average target price set by institutions is 59.1 yuan [4]

Core Viewpoint - The stock of Steady Medical (300888) has shown a slight increase of 1.4% on August 18, 2025, with a closing price of 41.42 yuan, amidst mixed capital flows indicating a net outflow from major and retail investors while institutional investors have a positive outlook on the stock [1][4]. Group 1: Stock Performance - On August 18, 2025, Steady Medical's stock closed at 41.42 yuan, up by 1.4%, with a turnover rate of 5.16% and a trading volume of 90,500 lots, resulting in a transaction amount of 374 million yuan [1]. - The capital flow data for August 18 indicates a net outflow of 22.53 million yuan from major investors, accounting for 6.02% of the total transaction amount, while retail investors saw a net inflow of 39.60 million yuan, representing 10.58% of the total [1][2]. Group 2: Financial Metrics and Industry Ranking - Steady Medical's total market capitalization is 24.12 billion yuan, with a net asset value of 12.15 billion yuan, and a net profit of 249 million yuan, ranking 4th, 1st, and 3rd respectively in the beauty and personal care industry [3]. - The company's first-quarter report for 2025 shows a main revenue of 2.605 billion yuan, a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up by 36.26% [3]. - The company's gross margin stands at 48.46%, which is higher than the industry average of 42.27%, while the net margin is 10.05%, compared to the industry average of 8.48% [3]. Group 3: Institutional Ratings - In the last 90 days, 15 institutions have rated Steady Medical, with 13 buy ratings and 2 hold ratings, indicating a generally positive sentiment towards the stock [4]. - The average target price set by institutions over the past 90 days is 59.1 yuan, suggesting potential upside from the current trading price [4].

Group 1 - The stock of Steady Medical (300888) closed at 40.85 yuan on August 15, 2025, with an increase of 1.44% and a turnover rate of 3.75% [1] - The net outflow of main funds was 20.47 million yuan, accounting for 7.65% of the total turnover, while retail investors had a net inflow of 34.56 million yuan, representing 12.92% of the total turnover [1][2] Group 2 - Over the past five days, the stock experienced fluctuations, with a peak closing price of 41.08 yuan on August 13, 2025, and a low of 40.27 yuan on August 14, 2025 [2] - The company reported a total market value of 23.788 billion yuan, with a net profit of 249 million yuan, reflecting a year-on-year increase of 36.26% [3] - The company's gross profit margin stood at 48.46%, which is higher than the industry average of 42.27% [3] Group 3 - In the last 90 days, 15 institutions provided ratings for the stock, with 13 buy ratings and 2 hold ratings, and the average target price set at 59.1 yuan [4]

Core Viewpoint - The stock of Steady Medical (300888) has shown a slight increase, with significant net inflows from retail investors despite outflows from institutional and speculative funds [1][2]. Group 1: Stock Performance - As of August 13, 2025, Steady Medical's stock closed at 41.08 yuan, up by 0.37%, with a turnover rate of 5.42% and a trading volume of 95,200 lots, amounting to a transaction value of 390 million yuan [1]. - In the past five days, the stock experienced fluctuations in net fund flows, with a notable net outflow of 34.4 million yuan from institutional investors on August 13, representing 8.81% of the total transaction value [2]. Group 2: Financial Metrics - Steady Medical's total market capitalization is 23.922 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company reported a net profit of 249 million yuan for the first quarter of 2025, reflecting a year-on-year increase of 36.26%, with a gross margin of 48.46% [3]. Group 3: Analyst Ratings - Over the past 90 days, 16 institutions have provided ratings for Steady Medical, with 13 buy ratings and 3 hold ratings, and the average target price set at 57.38 yuan [4].

Core Viewpoint - The stock of Steady Medical (300888) has shown a slight decline, with significant net outflows from major and retail investors, while the company continues to demonstrate strong financial performance in its recent quarterly report [1][3]. Financial Performance - As of August 11, 2025, Steady Medical's stock closed at 40.5 yuan, down 0.07% with a trading volume of 68,500 hands and a transaction amount of 277 million yuan [1]. - The company reported a main revenue of 2.605 billion yuan for Q1 2025, representing a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up 36.26% year-on-year [3]. - The company's gross profit margin stands at 48.46%, with a net profit margin of 10.05% [3]. Market Position - Steady Medical has a total market value of 23.584 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company has a price-to-earnings ratio (P/E) of 23.72, which is lower than the industry average of 41.33, indicating a potentially undervalued stock [3]. Investor Sentiment - Over the past 90 days, 16 institutions have rated the stock, with 13 buy ratings and 3 hold ratings, suggesting a positive outlook among analysts [4]. - The average target price set by institutions for the stock is 57.38 yuan, indicating potential upside from the current trading price [4]. Capital Flow - On August 11, 2025, the net outflow of major funds was 21.937 million yuan, accounting for 7.93% of the total transaction amount, while retail investors saw a net inflow of 24.797 million yuan, representing 8.96% of the total [1][2].

Group 1 - The stock price of Steady Medical (300888) closed at 40.11 yuan on August 1, 2025, with a slight increase of 0.28% and a trading volume of 46,200 hands, resulting in a transaction amount of 186 million yuan [1] - The net inflow of main funds was 611,700 yuan, accounting for 0.33% of the total transaction amount, while retail investors experienced a net outflow of 2,040,820 yuan, representing 11.0% of the total transaction amount [1] - Over the past five days, the stock has seen fluctuations in fund flows, with significant net outflows from main funds on July 31, 2025, amounting to 27.43 million yuan [1] Group 2 - Steady Medical's total market value is 23.357 billion yuan, ranking 4th in the beauty and personal care industry, which has an average market value of 10.844 billion yuan [2] - The company reported a net profit of 249 million yuan for Q1 2025, reflecting a year-on-year increase of 36.26%, with a gross profit margin of 48.46% [2] - The company's return on equity (ROE) stands at 2.13%, which is higher than the industry average of 1.91% [2] Group 3 - In the last 90 days, 22 institutions have rated the stock, with 18 buy ratings and 4 hold ratings, and the average target price set by institutions is 58.04 yuan [3]

Core Viewpoint - The stock of Steady Medical (300888) has experienced a decline, with significant net outflows from major funds, indicating potential concerns among institutional investors [1][2]. Financial Performance - As of July 31, 2025, Steady Medical's stock closed at 40.00 yuan, down 2.32%, with a trading volume of 67,000 hands and a transaction amount of 270 million yuan [1]. - The company reported a main revenue of 2.605 billion yuan for Q1 2025, a year-on-year increase of 36.47%, and a net profit attributable to shareholders of 249 million yuan, also up 36.26% year-on-year [3]. - The company's gross profit margin stands at 48.46%, which is higher than the industry average of 42.27% [3]. Market Position - Steady Medical has a total market value of 23.293 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company's price-to-earnings ratio (P/E) is 23.43, which is lower than the industry average of 39.83, indicating a potentially undervalued stock [3]. Fund Flow Analysis - On July 31, 2025, the net outflow of major funds was 27.4298 million yuan, accounting for 10.15% of the total transaction amount, while retail investors saw a net inflow of 7.5146 million yuan, representing 2.78% of the total [1][2]. - Over the past five days, the stock has seen fluctuating fund flows, with significant net outflows from major funds on multiple days [2]. Institutional Ratings - In the last 90 days, 23 institutions have rated the stock, with 19 buy ratings and 4 hold ratings, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions over the past 90 days is 58.04 yuan, suggesting potential upside from the current trading price [4].